Brief: China Resources Pharmaceutical Sees FY Net Profit Attributable Of Dong-E-E-Jiao RMB1,500 Million To RMB1,600 Million
17/01/2025 15:38
Jan 17 (Reuters) - China Resources Pharmaceutical
3320.HK :
* SEES NET PROFIT ATTRIBUTABLE OF DONG-E-E-JIAO FOR YEAR
RMB1,500
MILLION TO RMB1,600 MILLION
Further company coverage: 000423.SZ
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals